Publications by authors named "Mark R Nathan"

4Publications

A Review of Fulvestrant in Breast Cancer.

Authors:
Mark R Nathan Peter Schmid

Oncol Ther 2017 8;5(1):17-29. Epub 2017 May 8.

St Bartholomew's Hospital, London, UK.

View Article and Find Full Text PDF
May 2017

The emerging world of breast cancer immunotherapy.

Authors:
Mark R Nathan Peter Schmid

Breast 2018 Feb 2;37:200-206. Epub 2017 Jun 2.

St Bartholomew's Hospital, London, UK.

View Article and Find Full Text PDF
February 2018

Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.

Authors:
Victoria L Bridgeman Peter B Vermeulen Shane Foo Agnes Bilecz Frances Daley Eleftherios Kostaras Mark R Nathan Elaine Wan Sophia Frentzas Thomas Schweiger Balazs Hegedus Konrad Hoetzenecker Ferenc Renyi-Vamos Elizabeth A Kuczynski Naveen S Vasudev James Larkin Martin Gore Harold F Dvorak Sandor Paku Robert S Kerbel Balazs Dome Andrew R Reynolds

J Pathol 2017 Feb 29;241(3):362-374. Epub 2016 Dec 29.

Tumour Biology Team, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.

View Article and Find Full Text PDF
February 2017

Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma.

Authors:
Victoria L Bridgeman Elaine Wan Shane Foo Mark R Nathan Jonathan C Welti Sophia Frentzas Peter B Vermeulen Natasha Preece Caroline J Springer Thomas Powles Paul D Nathan James Larkin Martin Gore Naveen S Vasudev Andrew R Reynolds

Mol Cancer Ther 2016 Jan 20;15(1):172-83. Epub 2015 Oct 20.

Tumour Biology Team, The Breast Cancer Now Toby Robins Research Centre, Mary-Jean Mitchell Green Building, The Institute of Cancer Research (ICR), London, United Kingdom.

View Article and Find Full Text PDF
January 2016